Invention Grant
US08945510B2 Radiolabeled glutaminyl cyclase (QC) inhibitors and uses of same
有权
放射性标记的谷氨酰胺环化酶（QC）抑制剂及其用途
- Patent Title: Radiolabeled glutaminyl cyclase (QC) inhibitors and uses of same
- Patent Title (中): 放射性标记的谷氨酰胺环化酶（QC）抑制剂及其用途
-
Application No.: US13479826Application Date: 2012-05-24
-
Publication No.: US08945510B2Publication Date: 2015-02-03
- Inventor: Ulrich Heiser , Daniel Ramsbeck , Hans-Ulrich Demuth
- Applicant: Ulrich Heiser , Daniel Ramsbeck , Hans-Ulrich Demuth
- Applicant Address: DE Halle/Saale
- Assignee: Probiodrug AG
- Current Assignee: Probiodrug AG
- Current Assignee Address: DE Halle/Saale
- Agency: Dentons US LLP
- Main IPC: A61K51/04
- IPC: A61K51/04 ; A61K31/415 ; C07D403/10
Abstract:
Radiolabeled glutaminylcyclase (QC) inhibitors as imaging agents, in particular, but not exclusively, as medical imaging agents for the detection of neurological disorders; and pharmaceutical compositions, methods and kits for detecting neurological disorders, using the radiolabeled inhibitors.
Public/Granted literature
- US20120301398A1 RADIOLABELLED GLUTAMINYL CYCLASE (QC) INHIBITORS AND USES OF SAME Public/Granted day:2012-11-29
Information query
